ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,329Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 2680

$1.56M Total Retail Price of All Prescriptions

Rank: 13 out of 2680

529 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 529 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 529 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 20,308 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

44% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 974 936 1 3
NEXIUM 965 959 2 19
SIMVASTATIN 854 788 3 1
ALENDRONATE SODIUM 635 608 4 20
LIDODERM 624 613 5 74
ENALAPRIL MALEATE 569 529 6 24
LOVAZA 538 530 7 47
ATENOLOL 523 507 8 14
CREON 521 515 9 112
TAMSULOSIN HCL 496 491 10 25
GEMFIBROZIL 454 419 10 11 119
NAPROXEN 407 387 12 91
CELEBREX 403 391 13 75
GLIPIZIDE XL 399 374 14 87
METFORMIN HCL 391 365 15 6
HYDROCHLOROTHIAZIDE 376 367 16 9
ZOLPIDEM TARTRATE 366 356 17 17
CRESTOR 327 321 18 15
AZITHROMYCIN 308 292 19 40
OMEPRAZOLE 306 273 20 2
ATORVASTATIN CALCIUM 305 293 21 10
CLOTRIMAZOLE-BETAMETHASONE 283 256 22 109
RANITIDINE HCL 254 235 23 35
DIOVAN HCT 201 182 24 54
CLOPIDOGREL 198 186 25 30
ATELVIA 198 185 25 164
MECLIZINE HCL 189 180 27 105
METOPROLOL TARTRATE 188 183 28 8
CIPROFLOXACIN HCL 184 181 29 85
HYDROCORTISONE VALERATE 177 170 30 275
GABAPENTIN 175 174 31 21
FUROSEMIDE 171 171 32 7
PLAVIX 160 157 33 41
DONEPEZIL HCL 159 157 34 28
PROAIR HFA 150 146 35 52
ROPINIROLE HCL 146 146 36 143
LEVOTHYROXINE SODIUM 138 122 37 4
PATADAY 137 137 38 261
SINGULAIR 127 126 39 64
CARVEDILOL 126 120 40 27
VOLTAREN 126 116 40 103
FLUTICASONE PROPIONATE 121 112 42 38
DIOVAN 121 118 42 26
LYRICA 120 114 44 107
LIPITOR 114 111 45 78
LISINOPRIL 113 112 46 5
JANUVIA 112 83 47 34
IBANDRONATE SODIUM 106 103 48 223
PAROXETINE HCL 106 101 48 62
ACTOS 106 106 48 98
ATENOLOL-CHLORTHALIDONE 103 103 51 182
AMOXICILLIN 100 98 52 142
LOSARTAN POTASSIUM 98 97 53 18
WARFARIN SODIUM 98 98 53 12
METOPROLOL SUCCINATE 94 94 55 11
GLYBURIDE-METFORMIN HCL 94 94 R 55 96
BONIVA 93 87 57 228
ADVAIR DISKUS 88 82 58 32
METHYLPREDNISOLONE 87 81 59 236
HYDROCODONE-ACETAMINOPHEN 85 83 S3 60 13
AVODART 83 83 61 165
EXFORGE 82 82 62 139
LOSARTAN-HYDROCHLOROTHIAZIDE 82 79 62 46
GLIMEPIRIDE 82 82 62 51
NIFEDIPINE ER 80 80 65 73
NASONEX 75 75 66 206
GLIPIZIDE ER 72 61 67 116
IBUPROFEN 68 61 68 63
BETAMETHASONE DIPROPIONATE 67 67 69 258
FEXOFENADINE HCL 63 63 70 389
MEGACE ES 62 62 R 71 421
SOLARAZE 62 62 71 172
KETOCONAZOLE 61 61 73 244
AMLODIPINE BESYLATE-BENAZEPRIL 60 60 74 58
GLIPIZIDE 60 44 74 71
TRICOR 57 46 76 115
AMMONIUM LACTATE 57 52 76 118
BENICAR HCT 57 57 76 125
THEOPHYLLINE ANHYDROUS 57 52 76 336
NAMENDA 56 56 80 43
MONTELUKAST SODIUM 53 52 81 134
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.